Serotonergic modulation and irritable bowel syndrome

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.6, Iss.1, 2001-04, pp. : 57-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Risk of Ischaemic Colitis in Irritable Bowel Syndrome Patients Treated with Serotonergic Therapies

By Lewis James H.

Drug Safety, Vol. 34, Iss. 7, 2011-07 ,pp. : 545-565

Adis International

Access to resources Recommend Favorite

Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea

By Chey William D Cash Brooks D

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 185-193

Informa Healthcare

Access to resources Recommend Favorite

Alosetron and irritable bowel syndrome

By Mayer Emeran A Bradesi Sylvie

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2089-2098

Informa Healthcare

Access to resources Recommend Favorite

Irritable Bowel Syndrome

By Spinelli Antonella

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 15-33

Adis International

Access to resources Recommend Favorite

Quality of Life in Irritable Bowel Syndrome

By Lea R. Whorwell P.J.

PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. : 643-653

Adis International

Access to resources Recommend Favorite